Twitter.com


Profile_bird

Hey there! eyeonfda is using Twitter.

Twitter is a free service that lets you keep in touch with people using the web, your phone, or IM. Join today to start receiving eyeonfda's updates.

Already using Twitter via SMS or IM? Finish signing up.

About

Following

BBC Health Kerri | SixUntilMe Barack Obama NYTimes: Science Health Warehouse womenshealth.gov First Watch MD News NASA eddyevans Les Morgan Tom Lamb romanholiday pharmalot USAgov RachelleLacroix lukemerk pharmaguy katieobriendc Public_Citizen PatCleary PharmaTelevision brianreid Fard Johnmar nicoleatbio Food Safety Info Ctr NIHforHealth tevapharm prweekstaff


eyeonfda

FDA Approves DNA Test to Measure Hepatitis B Virus Levels - http://tinyurl.com/6z6dzy

Celgene Announces Amrubicin Gets FDA Fast for Treatment of Small Cell Lung Cancer after 1st-Line Chemotherapy - http://tinyurl.com/5k4kqj
FDA: Manufacturers of TNF-Blocker Drugs Must Highlight Risk of Fungal Infections - http://tinyurl.com/6aw662
VISTAKON® Brings ACUMINDER™ to Facebook Users - http://tinyurl.com/5spvpc
Sandoz receives FDA approval for Omnitrope® Pen 10 with liquid cartridge - http://tinyurl.com/5slwbt
Rasilez® 1st n class direct renin inhibitor lowers high blood pressure more than diuretic in obese patients - http://tinyurl.com/6lo4at
Pfizer and Medivation Agree to Co-Develop/Market Dimebon for Treatment of Alzheimer’s + Huntington’s Diseases http://tinyurl.com/678jly
NIH Announces that NTP FINALIZES REPORT ON BISPHENOL A - http://tinyurl.com/67kts4
Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Mallinckrodt Inc. - http://tinyurl.com/5pwblx
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to 6 Months-http://tinyurl.com/6xxufb
Celgene reports study published - REVLIMID(R) Demonstrates Activity against Relapsed/Refractory Aggressive NHL - http://tinyurl.com/6blba3
Bayer Submits Recombinant Human Thrombin for EMEA Approval Recothrom® astopical aid to surgical hemostasis http://tinyurl.com/6b3bxv
GSK’s darapladib modifies coronary plaque composition; lowers Lp-PLA2 activity, a risk predictor heart attack http://tinyurl.com/5tmcyp
Lipitor 80 mg - Sustained Risk Reduction of CV Events in Patients with Heart Disease During 5-Year TNT Trial - http://tinyurl.com/64auwc
Novartis decides not to pursue further development of Aurograb(TM) - http://tinyurl.com/5nrvk4
INTELENCE™ (etravirine) Receives Marketing Authorisation In The European Union For HIV Combination Therapy - http://tinyurl.com/65bemk
Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE® - http://tinyurl.com/6aq6wu
Low Levels of Brain Chemical May Lead to Obesity, NIH Study of Rare Disorder Shows - http://tinyurl.com/5uvybx
GSK and Valeant Pharmaceuticals announce worldwide collaboration agreement for retigabine - http://tinyurl.com/6d7tvo
FDA Clears Test to Help Doctors Manage Heart Transplant Patients-http://tinyurl.com/6587xk